918207.fig.001a
(a) Doxorubicin
918207.fig.001b
(b) Epirubicin
918207.fig.001c
(c) Cisplatin
918207.fig.001d
(d) Flutamide
Figure 1: Dose-response curves resulting from incubation of PC3 cell line with doxorubicin (a), epirubicin (b), cisplatin (c), and flutamide (d). Each experiment was performed in duplicate and repeated in three different sets of tests.